Hereditary Cancer Panels
Our Hereditary Panels analyze the most frequent syndromes that present predisposition to cancer, which may lead to the development of tumors such as: breast and ovarian, colorectal, prostate, lung, as well as genes that are associated with an increased susceptibility to the development of neoplasia.
Non-Invasive Prenatal Testing (NIPT)
Verifi® by Selecta Labs is a simple blood test that screens for the most common chromosomal abnormalities that can affect your baby’s future health. A sample can be drawn in your doctor’s office as early as the 10th week of pregnancy, and it may help you avoid more invasive procedures, such as amniocentesis or chorionic villus sampling (CVS), which are not without risks to you and your baby.